StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
75
This year
1
Publishing Date
2023 - 11 - 01
2
2023 - 03 - 02
1
2023 - 02 - 27
1
2023 - 02 - 07
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 11 - 23
1
2022 - 11 - 03
1
2022 - 10 - 26
1
2022 - 10 - 12
1
2022 - 10 - 06
1
2022 - 10 - 04
1
2022 - 09 - 29
1
2022 - 09 - 15
1
2022 - 08 - 03
1
2022 - 07 - 11
1
2022 - 06 - 21
1
2022 - 05 - 31
1
2022 - 05 - 05
2
2022 - 05 - 04
1
2022 - 04 - 27
1
2022 - 04 - 13
1
2022 - 03 - 17
1
2022 - 02 - 23
1
2022 - 02 - 17
1
2022 - 02 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 02 - 02
1
2022 - 01 - 09
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 15
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 19
1
2021 - 10 - 25
1
2021 - 10 - 04
1
2021 - 09 - 06
1
2021 - 08 - 25
1
2021 - 07 - 28
1
2021 - 07 - 21
1
2021 - 07 - 15
1
2021 - 07 - 14
1
2021 - 07 - 02
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 15
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 19
1
2021 - 05 - 18
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 28
1
2021 - 04 - 15
1
2021 - 04 - 13
1
2021 - 03 - 20
1
2021 - 02 - 25
1
2021 - 02 - 24
1
Sector
Finance
2
Health technology
75
Manufacturing
2
Tags
25000 people
1
Achondroplasia
9
Agreement
1
America
1
Application
6
Approval
2
Authorized
2
Biopharma
1
Cardio
1
Cardiovascular
1
Care
1
Cel
1
Ceo
1
Ces
1
Children
8
Chmp
1
Clinical hold
1
Collaboration
1
Conference
21
Day
2
Disease
2
Drop
4
Drug
2
Endocrine
1
Europe
5
Extension
1
Fda
6
Fda approval
1
Financial
4
Financial results
7
Food
1
Gene therapies
4
Gene therapy
7
Genetic
1
Genomic
1
Genomics
1
Germany
1
Global
1
Grant
1
Granted
2
Growth
9
Haemophilia
1
Health
2
Injection
4
International
2
License
2
Meeting
2
N/a
75
Ongoing
4
Phase 1
4
Phase 3
3
Presentation
3
Program
2
Results
13
Therapy
12
Total
2
Treatment
5
Trial
2
Voxzogo
7
Year
2
Entities
Arrival
2
Biomarin pharmaceutical inc.
75
Glaxosmithkline plc
1
Icon plc
1
Morgan stanley
2
Novartis ag
1
Sanofi
10
Syros pharmaceuticals, inc.
1
Turning point therapeutics, inc.
1
Symbols
ARVL
2
BMRN
75
GLAXF
1
GSK
1
ICLR
1
MS
2
NVS
1
NVSEF
1
SNY
10
SNYNF
7
SYRS
1
TPTX
1
Exchanges
Nasdaq
75
Nyse
3
Crawled Date
2023 - 11 - 01
2
2023 - 03 - 07
1
2023 - 03 - 02
1
2023 - 02 - 27
1
2023 - 02 - 07
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 11 - 23
1
2022 - 11 - 03
1
2022 - 10 - 26
1
2022 - 10 - 12
1
2022 - 10 - 06
1
2022 - 10 - 04
1
2022 - 09 - 29
1
2022 - 09 - 15
1
2022 - 08 - 03
1
2022 - 07 - 11
1
2022 - 06 - 21
1
2022 - 05 - 31
1
2022 - 05 - 05
2
2022 - 05 - 04
1
2022 - 04 - 27
1
2022 - 04 - 13
1
2022 - 03 - 17
1
2022 - 02 - 23
1
2022 - 02 - 17
1
2022 - 02 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 02 - 02
1
2022 - 01 - 09
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 15
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 19
1
2021 - 10 - 25
1
2021 - 10 - 04
1
2021 - 09 - 06
1
2021 - 08 - 25
1
2021 - 07 - 28
1
2021 - 07 - 21
1
2021 - 07 - 15
1
2021 - 07 - 14
1
2021 - 07 - 02
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 15
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 19
1
2021 - 05 - 18
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 28
1
2021 - 04 - 15
1
2021 - 04 - 13
1
2021 - 03 - 20
1
2021 - 03 - 08
2
Crawled Time
06:00
1
11:00
1
12:00
3
12:30
2
13:00
28
13:20
1
13:30
2
14:00
7
14:30
1
15:30
1
16:20
1
19:00
1
19:44
2
20:00
10
20:20
1
21:00
4
22:00
8
23:00
1
Source
amplitude.com
91
beamforall.com
172
feed.businesswire.com
386
hightideinc.com
206
investor.alkermes.com
92
investors.biomarin.com
75
ir.kalvista.com
85
jaguarhealth.gcs-web.com
189
mdxhealth.com
111
spacfeed.com
9999
velodynelidar.com
233
wodrs.com
252
www.petrosharecorp.com
77
www.adnas.com
77
www.amcnetworks.com
140
www.biospace.com
30692
www.blinkcharging.com
146
www.bmt.com
124
www.brainsway.com
208
www.canalaska.com
76
www.clinuvel.com
105
www.concentrix.com
348
www.confluent.io
269
www.cumulusmedia.com
147
www.duckcreek.com
114
www.emmis.com
149
www.extremenetworks.com
527
www.fatetherapeutics.com
150
www.fda.gov
96
www.globenewswire.com
93031
www.infinera.com
88
www.innodata.com
106
www.iridium.com
93
www.izea.com
121
www.j2global.com
92
www.kopin.com
80
www.limoneira.com
373
www.lomiko.com
90
www.marchex.com
124
www.middleby.com
240
www.myfw.com
130
www.nanthealth.com
90
www.nexstar.tv
183
www.nxtenergy.com
106
www.phunware.com
202
www.prnewswire.com
68898
www.progyny.com
195
www.repay.com
81
www.rubiconproject.com
168
www.sailpoint.com
80
www.shutterstock.com
121
www.spigroups.com
87
www.steelcase.com
132
www.sutrobio.com
164
www.taylordevices.com
82
www.thehackettgroup.com
88
www.veritone.com
173
www.vynetherapeutics.com
114
www.whirlpoolcorp.com
209
www.wisekey.com
152
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
exchanges :
Nasdaq
source :
Investors.biomarin.com
save search
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA
Published:
2024-01-03
(Crawled : 13:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-7.34%
|
O:
0.96%
H:
0.0%
C:
-2.33%
conference
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Germany
Published:
2023-11-28
(Crawled : 14:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
2.54%
|
O:
-0.21%
H:
0.12%
C:
-0.74%
roctavian
health
germany
insurance
agreement
BioMarin Announces Retirement of Jean-Jacques Bienaimé; Appoints Alexander Hardy President and Chief Executive Officer
Published:
2023-11-01
(Crawled : 20:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
8.14%
|
O:
-3.58%
H:
0.93%
C:
-1.64%
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year
Published:
2023-11-01
(Crawled : 20:00)
- investors.biomarin.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
0.5%
|
O:
3.0%
H:
0.0%
C:
0.0%
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
8.14%
|
O:
-3.58%
H:
0.93%
C:
-1.64%
year
total
growth
BioMarin to Present Data Showing Long-Term Benefit of VOXZOGO® (vosoritide) on Growth in Children with Achondroplasia at 2023 European Society for Paediatric Endocrinology (ESPE) Meeting
Published:
2023-09-21
(Crawled : 14:30)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
2.79%
|
O:
-0.68%
H:
0.52%
C:
-1.72%
voxzogo
children
achondroplasia
meeting
growth
BioMarin to Present Pipeline at Upcoming R&D Day on Tuesday, September 12th
Published:
2023-09-06
(Crawled : 13:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
0.12%
|
O:
-0.43%
H:
1.25%
C:
0.72%
day
pipeline
BioMarin to Participate in Three Upcoming Investor Conferences
Published:
2023-09-05
(Crawled : 12:30)
- investors.biomarin.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
5.34%
|
O:
0.01%
H:
0.0%
C:
0.0%
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-2.34%
|
O:
-0.59%
H:
0.14%
C:
-1.88%
BioMarin to Host Second-Quarter 2023 Financial Results Conference Call and Webcast on Monday, July 31, at 4:30pm ET
Published:
2023-07-12
(Crawled : 13:20)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
6.57%
|
O:
0.12%
H:
0.88%
C:
-0.13%
conference
financial
results
U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe Hemophilia A
Published:
2023-06-29
(Crawled : 19:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
2.16%
|
O:
1.2%
H:
1.97%
C:
-3.69%
drug
food
therapy
BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec) Data from Longest and Largest Hemophilia Gene Therapy Clinical Trial Program at the International Society on Thrombosis and Haemostasis (ISTH) 2023 Congress
Published:
2023-06-22
(Crawled : 12:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-5.7%
|
O:
-0.32%
H:
0.18%
C:
-0.44%
international
program
trial
therapy
BioMarin to Participate in Bank of America 2023 Health Care Conference
Published:
2023-05-04
(Crawled : 20:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-4.82%
|
O:
0.36%
H:
1.41%
C:
0.88%
america
conference
health
care
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
Published:
2023-04-26
(Crawled : 20:00)
- investors.biomarin.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-20.62%
|
O:
-3.56%
H:
0.0%
C:
0.0%
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-2.31%
|
O:
-1.0%
H:
1.46%
C:
0.41%
total
growth
BioMarin to Host First Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, April 26, at 4:30pm ET
Published:
2023-04-13
(Crawled : 13:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-7.26%
|
O:
-0.66%
H:
1.71%
C:
1.06%
conference
financial
results
BioMarin to Share Updated Data at 2023 American College of Medical Genetics and Genomics (ACMG) Meeting Demonstrating Commitment to Understanding Long-Term Benefit of VOXZOGO® in Children with Achondroplasia
Published:
2023-03-14
(Crawled : 12:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
0.92%
|
O:
1.61%
H:
0.11%
C:
-1.33%
voxzogo
meeting
children
medical
genomics
achondroplasia
FDA Accepts BioMarin's Supplemental New Drug Application to Expand Use of VOXZOGO® (vosoritide) for Injection to Treat Children with Achondroplasia Under the Age of 5
Published:
2023-03-07
(Crawled : 22:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-2.75%
|
O:
0.12%
H:
1.14%
C:
0.83%
voxzogo
fda
drug
children
application
achondroplasia
injection
BioMarin to Participate in Three Investor Conferences in March
Published:
2023-03-02
(Crawled : 14:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-10.04%
|
O:
-0.59%
H:
0.4%
C:
-0.27%
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
Published:
2023-02-27
(Crawled : 22:00)
- investors.biomarin.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.38%
|
O:
-1.4%
H:
0.0%
C:
0.0%
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-12.0%
|
O:
-3.82%
H:
3.69%
C:
0.29%
voxzogo
global
year
growth
BioMarin to Host Fourth Quarter and Full-Year 2022 Financial Results Conference Call and Webcast on Monday, February 27, at 4:30 p.m. ET
Published:
2023-02-07
(Crawled : 13:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-19.01%
|
O:
-0.13%
H:
0.0%
C:
-0.64%
conference
financial
results
BioMarin to Present at 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at 10:30 am PT /1:30 pm ET, in San Francisco, CA
Published:
2023-01-04
(Crawled : 14:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-9.7%
|
O:
3.06%
H:
3.12%
C:
3.12%
conference
European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2
Published:
2023-01-03
(Crawled : 22:00)
- investors.biomarin.com
BMRN
|
News
S
|
$90.48
-0.43%
-0.43%
1.3M
|
Health Technology
|
-9.7%
|
O:
3.06%
H:
3.12%
C:
3.12%
voxzogo
children
extension
application
injection
achondroplasia
← Previous
1
2
3
4
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.